BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Radwa R. El-Tahan, Ahmed M. Ghoneim, Hosam Zaghloul. Dissection of two drug-targeted regions of Hepatitis C virus subtype 4a infecting Egyptian patientsVirus Genes 2020; 56(5): 564 doi: 10.1007/s11262-020-01776-y
2
Anissa Chouikha, Marwa Khedhiri, Hatem Triki, Walid Hammemi, Amel Sadraoui, Henda Touzi, Ahlem Ben Yahia, Amel Chtourou, Saba Gargouri, Lamia Feki Ben Rajah, Hela Hakim Karray, Henda Triki. Focus on hepatitis C virus genotype distribution in Tunisia prior to elimination: a 16-year retrospective studyArchives of Virology 2021; 166(2): 501 doi: 10.1007/s00705-020-04918-7
3
Naiema K. Ali, Ragaa R. Mohamed, Bothina E. Saleh, Manal M. Alkady, Eman S. Farag. Occult hepatitis C virus infection among haemodialysis patientsArab Journal of Gastroenterology 2018; 19(3): 101 doi: 10.1016/j.ajg.2018.09.001
4
Dina Ragab, Dalia Samaha, Nesrine Mohamed, Mona Rafik, Walid Abdel Hady. Chronic hepatitis C virus infection impairs natural killer cells–dendritic cells cross‐talk: An in vitro culture study Microbiology and Immunology 2021; 65(2): 76 doi: 10.1111/1348-0421.12858
5
Ali Jibran Mecci, Michelle Cheung. eLS2017; : 1 doi: 10.1002/9780470015902.a0024786
6
G. Sanchez Antolin, M. Testillano, J.M. Pascasio, I. Narvaez Rodriguez, M. Prieto, A. Otero, J.I. Herrero, M. Londoño, I. Fernandez Vazquez, L. Castells, Xavier Xiol, Maria Luisa Gonzalez Dieguez, Mario Romero Cristobal, Jose Antonio Pons Miñano, Sonia Pascual Bartolome, Jose Luis Montero, Ana Arencibia, Sara Lorente, Esther Molina, Maria Dolores Espinosa, Valentin Cuervas-Mons, Emilio Fabrega Garcia. Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation CohortTransplantation Proceedings 2016; 48(9): 3013 doi: 10.1016/j.transproceed.2016.08.034
7
Youssef M. Mosaad, Shereen S. Metwally, Raghda E. Farag, Zakeria F. Lotfy, Hosam E. AbdelTwab. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCVImmunological Investigations 2019; 48(3): 321 doi: 10.1080/08820139.2018.1527851
8
Sevin Kirdar, Neriman Aydin, Yasin Tiryaki, Bulent Ertugrul, Adil Coskun, Mehmet Bilgen. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factorsAPMIS 2018; 126(2): 109 doi: 10.1111/apm.12790
9
Andres Tabernilla, Ignacio Rego-Pérez, Marta Grandal, Berta Pernas, Sonia Pértega, Manuel Delgado, Ana Mariño, Hortensia Álvarez, Alvaro Mena, Iria Rodríguez-Osorio, Jose Domingo Pedreira, Francisco Javier Blanco, Eva Poveda. Brief Report: European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression Among HCV and HIV/HCV-Coinfected Patients From Northwest SpainJAIDS Journal of Acquired Immune Deficiency Syndromes 2016; 73(2): 149 doi: 10.1097/QAI.0000000000001097
10
Gadissa Bedada Hundie, V. Stalin Raj, Daniel GebreMichael, Suzan D. Pas, Bart L. Haagmans, Jason Blackard. Genetic diversity of hepatitis C virus in EthiopiaPLOS ONE 2017; 12(6): e0179064 doi: 10.1371/journal.pone.0179064
11
Ahmed Nagaty, Ekram W. Abd El-Wahab, Tatsuo Kanda. Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in EgyptPLOS ONE 2017; 12(10): e0184654 doi: 10.1371/journal.pone.0184654
12
Mohamed Aboushady, Ahmed Alwassief, Mohamed Abdelrazik, Dina Ziada, Hossam Shahba, Amr Elmestikawy, Ashraf Elbahrawy. Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual TherapyJournal of Interferon & Cytokine Research 2019; 39(9): 539 doi: 10.1089/jir.2019.0041
13
G. Camus, B. Han, T. Asselah, D. Hsieh, H. Dvory-Sobol, J. Lu, E. Svarovskaia, R. Martin, B. Parhy, M. D. Miller, D. M. Brainard, K. Kersey, A. Abergel, H. Mo. Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4Journal of Viral Hepatitis 2018; 25(2): 134 doi: 10.1111/jvh.12795
14
Allison M. Bell, Jamie L. Wagner, Katie E. Barber, Kayla R. Stover. Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis CInternational Journal of Hepatology 2016; 2016: 1 doi: 10.1155/2016/3852126
15
Mohamed A. Daw, Abdallah El-Bouzedi, Mohamed O. Ahmed, Aghnyia A. Dau, Mohamed M. Agnan. Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan AfricaTravel Medicine and Infectious Disease 2016; 14(5): 517 doi: 10.1016/j.tmaid.2016.05.020
16
Dalia Omran, Mohamed Alboraie, Rania A Zayed, Mohamed-Naguib Wifi, Mervat Naguib, Mohamed Eltabbakh, Mohamed Abdellah, Ahmed Fouad Sherief, Sahar Maklad, Heba Hamdy Eldemellawy, Omar Khalid Saad, Doaa Mohamed Khamiss, Mohamed El Kassas. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitationsWorld Journal of Gastroenterology 2018; 24(38): 4330-4340 doi: 10.3748/wjg.v24.i38.4330
17
Dimitrios Paraskevis, Evangelia Georgia Kostaki, Anna Kramvis, Gkikas Magiorkinis. Hepatitis C: Epidemiology, Prevention and Elimination2021; : 55 doi: 10.1007/978-3-030-64649-3_3
18
Moataz M. Sayed, Ahmed I. El-Shafie, Ahmed Fathy Hilal, Hoda A. Abdelsattar. Can hepatitis C virus core antigen be used as a reliable marker of viral load for hepatitis C virus infection in genotype 4?Egyptian Liver Journal 2017; 7(1 and 2): 1 doi: 10.1097/01.ELX.0000523559.96944.09
19
Andréa Monteiro Tarragô, Grenda Leite Pereira, Flamir da Silva Victória, Adriana Malheiro Alle Marie, Marilú Barbieri Victória. Sofosbuvir and daclatasvir combination therapy for current hepatitis C virus genotype 4 achieves SVR: a case report of HCV genotype 4 from the AmazonRevista da Sociedade Brasileira de Medicina Tropical 2017; 50(6): 861 doi: 10.1590/0037-8682-0094-2017
20
Patrick L. Iversen. Molecular Basis of Resilience2018; : 19 doi: 10.1007/978-3-319-98164-2_2
21
El‐Sayed Ibrahim, Mohamed Abdel‐Samiee, Mohamed I. Youssef, Helmy El‐Shazly, Abd‐ElAleem A.El‐Gendy, Ayman Ahmed Sakr, Doaa Elwazzan, Mervat Ragab Nassar, Amr Elshormilisy, Ahmad Madkour, Mostafa Kamal, Yasmine M. Amrousy, Sally Waheed Elkhadry, Eman Abdelsameea. Variceal recurrence 4 years post endoscopic band ligation in hepatitis C patients who achieved sustained virological response with oral direct‐acting antiviral therapyJournal of Viral Hepatitis 2021; 28(2): 279 doi: 10.1111/jvh.13426
22
Radwa R. El-Tahan, Ahmed M. Ghoneim, Hosam Zaghloul. 5′ UTR and NS5B-based genotyping of hepatitis C virus in patients from Damietta governorate, EgyptJournal of Advanced Research 2018; 10: 39 doi: 10.1016/j.jare.2018.01.004
23
Ehab H. Mattar, Hussein A. Almehdar, Vladimir N. Uversky, Elrashdy M. Redwan. Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4Molecular BioSystems 2016; 12(9): 2785 doi: 10.1039/C6MB00283H
24
Anne Boerekamps, Thomas Vanwolleghem, Marc van der Valk, Guido E. van den Berk, Marjo van Kasteren, Dirk Posthouwer, Anthonius S.M. Dofferhoff, Bart van Hoek, Dewkoemar Ramsoekh, Jelle Koopsen, Janke Schinkel, Eric Florence, Joop E. Arends, Bart J. Rijnders. 8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)Journal of Hepatology 2019; 70(3): 554 doi: 10.1016/j.jhep.2018.10.032
25
Nicola Coppola, Loredana Alessio, Lorenzo Onorato, Caterina Sagnelli, Margherita Macera, Evangelista Sagnelli, Mariantonietta Pisaturo. Epidemiology and management of hepatitis C virus infections in immigrant populationsInfectious Diseases of Poverty 2019; 8(1) doi: 10.1186/s40249-019-0528-6
26
Rania H. Khalifa, Rasha Mohamad Hosny Shahin, Reham Emad Eldin Aboukhalil, Mohamed A. Marie, Amr M. El-deeb, Nermine Magdi Riad. Digging more in the genetic risk prediction of hepatitis C virus epidemic in Egypt: Apoptosis genes polymorphisms in the susceptibility of hepatitis C virus and association with viral loadVirus Research 2017; 238: 35 doi: 10.1016/j.virusres.2017.05.025
27
Khalid S. Hassanien, El‐Sayed M. El‐Sayed, Raed S. Ismail, Zakarya M. Zakarya, Gouda K. Helal. Association between interleukin 28B polymorphism and sustained virological response to sofosbuvir plus daclatasvir in chronic hepatitis C genotype 4 Egyptian patientsJournal of Clinical Pharmacy and Therapeutics 2021;  doi: 10.1111/jcpt.13417